UPDATE 1-FDA allows early resubmission of Vivus obesity drug
* Says will not hold resubmission till completion of Fortress study (Follows alerts)
UPDATE 2-Vivus jumps as FDA OKs obesity drug early resubmission ...
UPDATE 2-Vivus jumps as FDA OKs obesity drug early resubmission ... it to make an early resubmission of a new drug application for its obesity .Read More
Vivus shares buoyed as FDA allows early resubmission on Qnexa ...
Vivus shares buoyed as FDA allows early resubmission on Qnexa ... UPDATE: Vivus soars after ... on an early resubmission of the obesity drug Qnexa. Last fall, of course, Vivus .Read More
VIVUS, Inc. - VIVUS Provides Regulatory Update on QNEXA
VIVUS Provides Regulatory Update on QNEXA ... for an early resubmission of the QNEXA New Drug Application for the treatment of obesity. The resubmission plan allows VIVUS to .Read More
FDA OKs early resubmission of Vivus diet drug | Reuters
for a narrower indication of its obesity drug ... FDA OKs early resubmission of Vivus diet drug ... profile has increased enough to allow .Read More
Vivus gets back in the race for weight-loss drug OK, resubmits ...
UPDATE: Vivus soars after experts offer ... Vivus shares buoyed as FDA allows early resubmission on Qnexa Vivus surges on fresh batch of promising obesity drug data.Read More
VIVUS Provides Regulatory Update on QNEXA
that allows for an early resubmission of the QNEXA New Drug Application for the treatment of obesity. The resubmission plan allows VIVUS ... UPDATE: VIVUS Announces Pricing .Read More
VIVUS Provides Regulatory Update on QNEXA -- MOUNTAIN VIEW, Calif ...
VIVUS Provides Regulatory Update on QNEXA ... for an early resubmission of the QNEXA New Drug Application for the treatment of obesity. The resubmission plan allows VIVUS to .Read More
VIVUS, Inc. (VVUS) Gives Regulatory Update on Its QNEXA Drug ...
plan that allows for an early resubmission of the QNEXA New Drug Application for the treatment of obesity. Based on the agreement, VIVUS ... Update on Its QNEXA Drug .Read More
VIVUS (VVUS) Gets FDA Approval for Early QNEXA NDA Resubmission
UPDATE: Citi (C ... on a plan that allows for an early resubmission of the QNEXA New Drug Application for the treatment of obesity. The resubmission plan allows VIVUS .Read More
VIVUS INC NPV : VIVUS Provides Regulatory Update on QNEXA | 4-Traders
INC NPV : VIVUS Provides Regulatory Update ... for an early resubmission of the QNEXA New Drug Application for the treatment of obesity. The resubmission plan allows VIVUS to .Read More
VIVUS, Inc. - Press Releases
The Obesity Society's Annual ... VIVUS Provides Regulatory Update on QNEXA Sep 15, 2011 ... on a plan that allows for an early resubmission of the QNEXA New Drug .Read More
FDA to discuss new Qnexa application: Vivus - MarketWatch
new drug application for Qnexa, an obesity treatment ... who take the drug. But the agency agreed in September to allow an early resubmission of Vivus's ... Radio Update: Stocks .Read More
10-K: VIVUS INC - MarketWatch
labeling, REMS, safety update, and drug ... plan that allowed for an early resubmission of the Qnexa NDA for the treatment of obesity. ... additional analyses to allow .Read More
Stockhouse
programs with the resubmission of the NDA for Qnexa for obesity ... assessment for obesity drugs ... VIVUS does not undertake an obligation to update or revise any .Read More
Summary of VIVUS INC - Yahoo! Finance
labeling, REMS, safety update, and drug ... plan that allowed for an early resubmission of the Qnexa NDA for the treatment of obesity. ... additional analyses to allow .Read More
